| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |